Workflow
佰仁医疗: 佰仁医疗董事、高级管理人员所持公司股份及其变动管理制度(2025年8月)

Core Viewpoint - The document outlines the management system for the shares held by the directors and senior management of Beijing Bairen Medical Technology Co., Ltd, detailing the procedures and regulations governing shareholding and trading activities [1][2]. Summary by Sections General Provisions - The system is established to clarify the procedures for managing shares held by directors and senior management, in accordance with relevant laws and regulations [1]. - It applies to all shares registered under the names of directors and senior management [1]. Shareholding and Trading Rules - Directors and senior management can sell shares through the Shanghai Stock Exchange or other legally permitted methods, adhering to commitments regarding holding periods and trading methods [2]. - Specific conditions under which share reduction is prohibited include resignation within six months, ongoing investigations, and other legal restrictions [4][5]. Reporting and Disclosure - Directors and senior management must report personal information to the Shanghai Stock Exchange within two trading days of changes, including new appointments or resignations [2][3]. - A written notice of trading plans must be submitted to the board secretary before any share transactions, and trading cannot occur without the secretary's feedback [8][9]. Responsibilities and Penalties - Directors and senior management must ensure that their relatives and associated entities do not engage in insider trading [10]. - Violations of trading regulations may result in disciplinary actions from the company and regulatory authorities, including the recovery of profits from illegal trades [11][12]. Appendices - An attachment outlines the notification format for share trading plans, including details on the number of shares, trading period, and price range [12].